PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Abbott Diagnostics, Abbott Park, IL, USA. Electronic address: mary.rodgers@abbott.com.\', \'Abbott Diagnostics, Abbott Park, IL, USA.\', \'Montefiore Medical Center, NY, USA.\', \'Medical University of South Carolina, SC, USA.\', \'Rush University Medical Center, IL, USA.\', \'University of California San Francisco, CA, USA.\', \'Guy\'s and St Thomas\' NHS Foundation, London, UK.\', \'Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.\', \'University of KwaZulu-Natal, Durban, South Africa.\', \'Institute for Health Research Epidemiological Surveillance and Training, Dakar, Senegal.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1386-6532(22)00016-610.1016/j.jcv.2022.105080
?:hasPublicationType
?:journal
  • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
is ?:pmid of
?:pmid
?:pmid
  • 35086043
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all